| Filed On | Filing |
|---|---|
| 14 Oct 2022 | 15-12G |
| 05 Oct 2022 |
Form 4: Biohaven Pharmaceutical Holding Co Ltd., 10% owner · Biohaven Ltd.
Acquired 35,839,857 shares (Other Transaction) · Disposed of 35,839,857 shares (Other Transaction) |
| 04 Oct 2022 | 25-NSE |
| 03 Oct 2022 |
Form 4: Childs John W, Director
Returned 3,035,001 shares to the issuer ($451M) · Disposed of 20,235 Stock Options (Right to Buy) (Disposition to Issuer) |
| 03 Oct 2022 |
Form 4: Buten Matthew, Chief Financial Officer
Returned 6,177 shares to the issuer ($917K) · Disposed of 37,500 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 26,000 Stock Options (Right to Buy) (Disposition to Issuer) |
| 03 Oct 2022 |
Form 4: Mehta Kishan, Director
Returned 10,640 shares to the issuer ($1.58M) · Disposed of 1,875 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 56,243 Stock Options (Right to Buy) (Disposition to Issuer) |
| 03 Oct 2022 |
Form 4: Tilton John, Chief Commercial Officer
Returned 6,682 shares to the issuer ($992K) · Disposed of 6,375 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 120,032 Stock Options (Right to Buy) (Disposition to Issuer) |
| 03 Oct 2022 |
Form 4: Coric Vlad, Director
Returned 922,941 shares to the issuer ($137M) · Disposed of 105,954 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 1,172,500 Stock Options (Right to Buy) (Disposition to Issuer) |
| 03 Oct 2022 |
Form 4: Heffernan Michael Thomas, Director
Disposed of 3,320 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 46,435 Stock Options (Right to Buy) (Disposition to Issuer) |
| 03 Oct 2022 |
Form 4: Gregory Julia P, Director
Disposed of 56,235 Stock Options (Right to Buy) (Disposition to Issuer) |
| 03 Oct 2022 |
Form 4: Jones William A Jr, CCO-Migraine & Common Disease
Returned 14,226 shares to the issuer ($2.11M) · Disposed of 24,250 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 150,000 Stock Options (Right to Buy) (Disposition to Issuer) |
| 03 Oct 2022 |
Form 4: Hugin Robert J, Director
Returned 2,900 shares to the issuer ($431K) · Disposed of 3,417 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 39,183 Stock Options (Right to Buy) (Disposition to Issuer) |
| 03 Oct 2022 |
Form 4: Antonijevic Irina, Director
Disposed of 5,070 Restricted Share Unit Award (Disposition to Issuer) |
| 03 Oct 2022 |
Form 4: Clark George C., VP, Chief Accounting Officer
Returned 4,292 shares to the issuer ($637K) · Disposed of 21,750 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 33,375 Stock Options (Right to Buy) (Disposition to Issuer) |
| 03 Oct 2022 |
Form 4: Bailey Gregory, Director
Returned 2,583,658 shares to the issuer ($384M) · Disposed of 56,235 Stock Options (Right to Buy) (Disposition to Issuer) |
| 03 Oct 2022 |
Form 4: Stock Elyse, Chief Medical Officer
Returned 16,464 shares to the issuer ($2.44M) · Disposed of 27,063 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 175,788 Stock Options (Right to Buy) (Disposition to Issuer) |
| 03 Oct 2022 |
Form 4: Conway Charles, Chief Scientific Officer
Returned 22,362 shares to the issuer ($3.32M) · Disposed of 22,000 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 252,727 Stock Options (Right to Buy) (Disposition to Issuer) |
| 03 Oct 2022 |
Form 4: Engelhart James, Strategic Advisor
Returned 15,900 shares to the issuer ($2.36M) · Disposed of 20,950 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 278,764 Stock Options (Right to Buy) (Disposition to Issuer) · 1 more |
| 03 Oct 2022 |
Form 4: Gentile Kimberly, SVP, Clinical Operations
Returned 11,653 shares to the issuer ($1.73M) · Disposed of 24,250 Restricted Share Unit Award (Disposition to Issuer) · Disposed of 231,022 Stock Options (Right to Buy) (Disposition to Issuer) |
| 03 Oct 2022 | POSASR |
Loading...
